首页 | 本学科首页   官方微博 | 高级检索  
     

环孢素A对儿茶酚胺诱导的大鼠心肌肥大的作用
引用本文:符民桂,王晓红,姜志胜,李淑莲,庞永政,刘乃硅,唐朝枢. 环孢素A对儿茶酚胺诱导的大鼠心肌肥大的作用[J]. 中华心血管病杂志, 2001, 29(1): 41-44,I001
作者姓名:符民桂  王晓红  姜志胜  李淑莲  庞永政  刘乃硅  唐朝枢
作者单位:北京大学第一医院心血管研究所
基金项目:国家自然科学基金重点项目资助(编号:39730220)
摘    要:
目的 观察环孢素A(CaA)对儿茶酚胺诱导的大鼠心肌肥大的作用。方法 雌性Wistar大鼠21只,实验分三组,每组7只:(1)单纯肥大组:给大鼠皮下注射异丙肾上腺素(5mg.kg^-1,d^-1),连续10d:(2)CsA治疗组:除注射异丙肾上腺素外,同时腹腔注射CsA(20mg.kg^-1,d^-1),连续10d;(3)对照组:不作特殊处理。三组大鼠计大小,组织形态,心系数以及心肌组织抑制钙调神经磷酸酶CaN,丝裂素活化蛋白激酶(MAPK)及蛋白激酶C(PKC)活性的变化。在培养的大鼠心肌细胞上,观察CsA对去甲肾上腺素(NE)刺激的^3H-亮氨酸掺入的影响。结果 单纯注射异丙肾上腺素组的大鼠心脏明显增大,心肌细胞肥大,排列紊乱,并出现广泛间质纤维化,CaA治疗组大鼠心脏未明显增大,但仍可见部分心肌纤维化,大鼠心重及心系数明显低于单纯肥大组(P<0.05)。肥大组大鼠心肌组织CaN活性明显高于对照组(P<0.05),CaA治疗组大鼠心肌组织CaN活性低于肥大组(P<005),三组大鼠心肌组织MAPK活性差异无显著性,但肥大组大鼠心肌组织PKC活性较对照组增高4倍(P<0.001),CsA治疗组的大鼠心肌组织PKC活性较肥大组下降50%(P<0.001),CsA可明显抑制NE刺激的大鼠心肌细胞^3H-亮氨酸掺入,结论 CaN信号通中可能以儿茶酚胺诱导的心肌肥大中起一定作用,CsA可阻滞儿茶酚胺诱导的心肌肥大,这种作用可能主要通过抑制CaN及PKC活性,阻断CaN和PKC介导的信号传导通路所致。

关 键 词:环孢素A 儿茶酚胺 心肌肥大 钙调神经磷酸酶 信号通路

Effect of cyclosporin A on cardiac hypertrophy induced by catecholamine in rat
Abstract:
Objectives To determine the effect of cyclosporin A on catecholamine-induced cardiac hypertrophy in rats. Methods The rats were divided into 3 groups: 1) Isoporoterenol-treated group: The rats were injected with isoporoterenol (5 mg*kg-1*d-1); 2) CsA-treated group: Except injection of isoporoterenol, the rats were treated by CsA (20 mg*kg-1*d-1) ; 3) Control group: without any treatment. The heart size, heart/body weight ratio, CaN, MAPK and PKC activity in heart tissues were measured. The effect of CsA to 3H-Leucine incorporation of cultured neonatal rat cardiac myocytes stimulated by norepinephrine was investegated. Results In the isoporoterenol-treated group, the heart size of each rat was increased, the myofibrillar disarray and myofibrilize was evident. The heart size of the rat treated with CsA was not inceased, and CsA treatment prevented the increase in heart/body weight ratio characteristic of the isoporoterenol-treated group. The calcineurin activity in hearts from isoporoterenol-treated group was increased (P<0.05) compared with that of the control group. CsA treatment can reduce the CaN activity in hearts. There was no significant differences in MAPK activity between the three groups, but the PKC activity in hearts from the isoporoterenol-treated group was dramaticly increased (P<0.001), which is reduced by 50% in CsA-treated rat's hearts. CsA can markedly prevent the increase in 3H-Leucine incorporation of cultrued neonatal rat cardiac myocytes promoted by norepinephrine. Conclusion Calcineurin dependent signal pathway may play a role in catecholamine-induced cardiac hypertrophy. CsA can prevent the cardiac hypertrophy by blocking calcineurin- and PKC-mediated signal transduction.
Keywords:Cyclosporin A  Catecholamine  Cardiac hypertrophy  Calcineurin  Signal pathway
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号